Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634617 · ClinicalTrials.gov registry record
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
A clinical trial of Endometrial Carcinoma and Malignant Uterine Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 310
- Enrollment target
- 1
- Study location
NCT04634617: Active study of Endometrial Carcinoma and Malignant Uterine Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT04634617 is a study of Endometrial Carcinoma and Malignant Uterine Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 310 participants, below the 379-participant average among 27 other Endometrial Carcinoma trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04634617, a study of Endometrial Carcinoma and Malignant Uterine Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 310 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies pelvic floor dysfunction and quality of life in uterine cancer survivors. Using questionnaires may help researchers learn more about the sexual function and quality of life in uterine cancer survivors.
Primary Outcome
Measured by the Pelvic Floor Distress Inventory-20. Descriptive statistics (i.e. frequencies, percentages, medians, ranges, means, standard deviations, measures of skewness and kurtosis), including 95% confidence intervals (CIs) will be computed for the measures derived by study cohort. Prevalence estimates along with exact 95% CIs will be computed. Logistic regression analysis will be used to assess the odds of PFD for treatment cohorts relative to the cohort of patient controls.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2020-01-09 |
| Est. Completion | 2027-04-11 |
What the registry record for NCT04634617 still lists
NCT04634617 is an observational study that tracks outcomes without assigning an intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 379-participant average among 27 other Endometrial Carcinoma trials with a reported enrollment target (18% lower).
The record links to 4 conditions, with Endometrial Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire Administration is the first listed.
NCT04634617 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04634617 about?
NCT04634617 is a clinical study titled "Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors". This trial studies pelvic floor dysfunction and quality of life in uterine cancer survivors. Using questionnaires may help researchers learn more about the sexual function and quality of life in uterine cancer survivors.
What is the current status of trial NCT04634617?
This trial is currently active not recruiting. The enrollment target is 310 participants. The study started on 2020-01-09. Estimated completion is 2027-04-11.
What conditions does trial NCT04634617 study?
This clinical trial studies the following conditions: Endometrial Carcinoma, Malignant Uterine Neoplasm, Uterine Corpus Sarcoma, Uterine Corpus Cancer.
What interventions are being tested in trial NCT04634617?
The interventions under investigation include: Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT04634617?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04634617 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04634617's enrollment target sits among peer trials
310 4th of 27 higher than 24 of 27 other Endometrial Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia
RECRUITING · NA
-
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
RECRUITING
-
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
RECRUITING
-
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RECRUITING · Phase 3
-
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
RECRUITING · Phase 1
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI